Safety of antiviral and anti-inflammatory drugs prolonging QT interval in patients with coronavirus disease 2019: an opinion of the Heart Rhythm Section of the Polish Cardiac Society

Elżbieta K. Biernacka; Dariusz A. Kosior; Agnieszka Zienciuk-Krajka; Maria Miszczak-Knecht; Maciej Kempa; Andrzej Przybylski

doi:10.33963/KP.15354

Vol 78, No 5 (2020)

Expert opinion

Published online: 2020-05-11

View PDF

Download PDF file

Get Citation

Safety of antiviral and anti-inflammatory drugs prolonging QT interval in patients with coronavirus disease 2019: an opinion of the Heart Rhythm Section of the Polish Cardiac Society

Elżbieta K. Biernacka, Dariusz A. Kosior, Agnieszka Zienciuk-Krajka, Maria Miszczak-Knecht, Maciej Kempa, Andrzej Przybylski

DOI: 10.33963/KP.15354

Pubmed: 32394693

Kardiol Pol 2020;78(5):493-497.

Vol 78, No 5 (2020)

Expert opinion and position paper

Published online: 2020-05-11

Abstract

Not available

Abstract

Not available

Full Text:

View PDF

Download PDF file

Get Citation

About this article

Title

Safety of antiviral and anti-inflammatory drugs prolonging QT interval in patients with coronavirus disease 2019: an opinion of the Heart Rhythm Section of the Polish Cardiac Society

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 78, No 5 (2020)

Article type

Expert opinion

Pages

493-497

Published online

2020-05-11

Page views

167

Article views/downloads

195

DOI

10.33963/KP.15354

Pubmed

32394693

Bibliographic record

Kardiol Pol 2020;78(5):493-497.

Authors

Elżbieta K. Biernacka
Dariusz A. Kosior
Agnieszka Zienciuk-Krajka
Maria Miszczak-Knecht
Maciej Kempa
Andrzej Przybylski